HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: 2443061355v1 244/3/776    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Choi, D. Articles by Herrine, S. K. Search for Related Content PubMed PubMed Citation Articles by Choi, D. Articles by Herrine, S. K.

Hepatocellular Carcinoma with Indeterminate or False-Negative Findings at Initial MR Imaging: Effect on Eligibility for Curative Treatment—Initial Observations¹

¹ From the Departments of Radiology (D.C., D.G.M., S.K.V., D.B.) and Medicine (V.J.N., A.B.M., C.M., H.L.H., S.K.H.), Thomas Jefferson University Hospital, 132 S 10th St, 1094 Main Bldg, Philadelphia, PA 19107. From the 2006 RSNA Annual Meeting. Received August 4, 2006; revision requested October 10; final revision received October 31; accepted December 6; final version accepted January 16, 2007. Address correspondence to D.G.M. (e-mail: donald.mitchell{at}jefferson.edu).

Purpose: To retrospectively evaluate the effect of indeterminate or false-negative findings at magnetic resonance (MR) imaging on eligibility for curative treatment of hepatocellular carcinoma (HCC).

Materials and Methods: This HIPAA-compliant retrospective study was approved by the institutional review board; the need for informed consent was waived. Of 166 patients with cirrhosis in whom HCC was detected with MR imaging, 21 (13 men, eight women; mean age, 60 years) had 33 proved HCCs that were not detected on previous MR images obtained 6–24 months earlier. MR imaging included T1-weighted, T2-weighted, and dynamic contrast material–enhanced T1-weighted imaging. Serial MR images and treatment records were reviewed to evaluate nodule growth and the effect of delayed diagnosis on treatment eligibility.

Results: Of 33 HCCs in 21 patients, 24 corresponding nodules (73%) were described on previous MR images as benign or indeterminate. Five additional nodules were visible at retrospective evaluation, but only on arterial phase images. The diameters of these 29 visible but indeterminate nodules were initially 0.6–1.9 cm (mean, 1.1 cm) and increased to 0.9–4.5 cm (mean, 1.9 cm) at HCC diagnosis (mean follow-up, 378 days). The mean doubling time was 856 days for diameter and 285 days for volume. All nine HCCs with a delayed diagnosis of less than 1 year were smaller than 3 cm at diagnosis, and the patients had undergone liver transplantation (n = 3) or technically successful ablation or embolization (n = 6). All 10 subcentimeter indeterminate nodules were smaller than 2 cm at HCC diagnosis, and none progressed to untreatable HCC.

Conclusion: Indeterminate nodules smaller than 2 cm did not become untreatable HCC with delayed HCC diagnosis of 6–12 months.

© RSNA, 2007

This article has been cited by other articles:

				Y. Park, D. Choi, H. K. Lim, H. Rhim, Y.-s. Kim, S. H. Kim, and W. J. Lee Growth Rate of New Hepatocellular Carcinoma After Percutaneous Radiofrequency Ablation: Evaluation with Multiphase CT Am. J. Roentgenol., July 1, 2008; 191(1): 215 - 220. [Abstract] [Full Text] [PDF]